Author:
Gebremedhin Amanuel Tesfay,Hogan Alexandra B.,Blyth Christopher C.,Glass Kathryn,Moore Hannah C.
Abstract
AbstractRespiratory syncytial virus (RSV) is a leading cause of childhood morbidity, however there is no systematic testing in children hospitalised with respiratory symptoms. Therefore, current RSV incidence likely underestimates the true burden. We used probabilistically linked perinatal, hospital, and laboratory records of 321,825 children born in Western Australia (WA), 2000–2012. We generated a predictive model for RSV positivity in hospitalised children aged < 5 years. We applied the model to all hospitalisations in our population-based cohort to determine the true RSV incidence, and under-ascertainment fraction. The model’s predictive performance was determined using cross-validated area under the receiver operating characteristic (AUROC) curve. From 321,825 hospitalisations, 37,784 were tested for RSV (22.8% positive). Predictors of RSV positivity included younger admission age, male sex, non-Aboriginal ethnicity, a diagnosis of bronchiolitis and longer hospital stay. Our model showed good predictive accuracy (AUROC: 0.87). The respective sensitivity, specificity, positive predictive value and negative predictive values were 58.4%, 92.2%, 68.6% and 88.3%. The predicted incidence rates of hospitalised RSV for children aged < 3 months was 43.7/1000 child-years (95% CI 42.1–45.4) compared with 31.7/1000 child-years (95% CI 30.3–33.1) from laboratory-confirmed RSV admissions. Findings from our study suggest that the true burden of RSV may be 30–57% higher than current estimates.
Funder
Wesfarmers Centre of Vaccines and Infectious Diseases
Imperial College Research Fellowship
MRC Centre for Global Infectious Disease Analysis
National Health and Medical Research Council
Publisher
Springer Science and Business Media LLC
Reference47 articles.
1. Shi, T. et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. The Lancet 390, 946–958 (2017).
2. Saravanos, G. L. et al. Respiratory syncytial virus-associated hospitalisations in Australia, 2006–2015. Med. J. Aust. 210, 447–453 (2019).
3. Lim, F. J., Blyth, C. C., Fathima, P., de Klerk, N. & Moore, H. C. Record linkage study of the pathogen-specific burden of respiratory viruses in children. Influenza Other Respir. Viruses 11, 502–510 (2017).
4. Moore, H. C. et al. Assessing the burden of laboratory-confirmed respiratory syncytial virus infection in a population cohort of Australian children through record linkage. J. Infect. Dis. 2, 106 (2020).
5. Müller-Pebody, B., Edmunds, W., Zambon, M., Gay, N. & Crowcroft, N. Contribution of RSV to bronchiolitis and pneumonia-associated hospitalizations in English children, April 1995–March 1998. Epidemiol. Infect. 129, 99–106 (2002).